Measurement techniques for respiratory tract deposition of airborne nanoparticles: A critical review

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 27, Issue 4, 2014, Pages 229-254

  Löndahl, Jakob ^a   Möller, Winfried ^b   Pagels, Joakim H ^a   Kreyling, Wolfgang G ^b   Swietlicki, Erik ^a   Schmid, Otmar ^b  

^a LUND UNIVERSITY   (Sweden)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

aerosol; dosimetry; engineered nanoparticles; health; inhalation; lung deposition; NSAM; pulmonary; ultrafine particles

Indexed keywords

NANOPARTICLE; AEROSOL; DRUG; PARTICULATE MATTER;

AEROSOL; AIR POLLUTION; AIRBORNE PARTICLE; HUMAN; INHALATION; MEASUREMENT ACCURACY; NANOTECHNOLOGY; PARAMETERS; PARTICLE SIZE; QUALITY CONTROL; RESPIRATORY SYSTEM; REVIEW; RISK ASSESSMENT; ADVERSE EFFECTS; ANATOMY AND HISTOLOGY; ANIMAL; AUDIOVISUAL EQUIPMENT; CHEMISTRY; DIFFUSION; EXPOSURE; INHALATIONAL DRUG ADMINISTRATION; LUNG; MEDICINAL CHEMISTRY; PARTICULATE MATTER; PHYSIOLOGY;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; HUMANS; INHALATION; INHALATION EXPOSURE; LUNG; MODELS, ANATOMIC; NANOPARTICLES; PARTICLE SIZE; PARTICULATE MATTER; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT;

EID: 84905443848     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2013.1044     Document Type: Review

References (134)

1. Paur HR, Cassee FR, Teeguarden J, Fissan H, Diabate S, Aufderheide M, Kreyling WG, Hanninen O, Kasper G, Riediker M, Rothen-Rutishauser B, and Schmid O: In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung - a dialog between aerosol science and biology. J Aerosol Sci. 2011;42:668-692.
2. Schmid O, Moller W, Semmler-Behnke M, Ferron GA, Karg E, Lipka J, Schulz H, Kreyling WG, and Stoeger T: Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers. 2009;14:67-73.
3. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, and Schulz H: Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect. 2006;114:328-333.
4. De Winter-Sorkina R, and Cassee FR: From concentration to dose: factors influencing airborne particulate matter deposition in humans and rats. National Institute of Public Health and the Environment. RIVM report 650010031. Bilthoven, The Netherlands; pp. 1-36, 2002.
5. ICRP: Human respiratory tract model for radiological protection. ICRP Publication 66. Ann ICRP. 1994;24(1-3).
6. Tyndall J: Essays on the Floating-Matter of the Air in Relation to Putrefaction and Infection. Longmans, Green, and Co., London; 1881.
7. Baumberger JP: The amount of smoke produced from tobacco and its absorption in smoking as determined by electrical precipitation. J Pharmacol Exp Ther. 1923;21: 47-57.
8. Drinker P, Thomson RM, and Finn JL: Quantitative measurements of the inhalation, retention, and exhalation of dusts and fumes by man: 1. Concentrations of 50 to 450mg per cubic meter. J Ind Hyg Toxicol. 1928;10:13-25.
9. Landahl HD, and Herrmann RG: On the retention of airborne particulates in the human lung. J Ind Hyg Toxicol. 1948;30:181-188.
10. van Wijk AM, and Patterson HS: The percentage of particles of different sizes removed from dust-laden air by breathing. J Ind Hyg Toxicol. 1940;22:31-35.
11. Krewski D, Burnett R, Jerrett M, Pope CA, Rainham D, Calle E, Thurston G, and Thun M: Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. J Toxicol Environ Health A. 2005;68:1093-1109.
12. Peters A, Wichmann HE, Tuch T, Heinrich J, and Heyder J: Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med. 1997;155:1376-1383.
13. Hänninen O, Brüske-Hohlfeld I, Loh M, Stoeger T, Kreyling W, Schmid O, and Peters A: Occupational and consumer risk estimates for nanoparticles emitted by laser printers. J Nanopart Res. 2010;12:91-99.
14. Oberdörster G, Oberdörster E, and Oberdörster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
15. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair- Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan- Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen HL, Chen JS, Cheng ATA, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FGR, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan HD, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CDH, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi PL, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJC, Steenland K, Stockl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJL, and Ezzati M: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380: 2224-2260.
16. Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, Karamanos N, and Zarogoulidis K: Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomed. 2012;7: 1551-1572.
17. Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, and Frampton MW: Ultrafine particle deposition in subjects with asthma. Environ Health Perspect. 2004;112:879-882.
18. Löndahl J, Pagels J, Swietlicki E, Zhou JC, Ketzel M, Massling A, and Bohgard M: A set-up for field studies of respiratory tract deposition of fine and ultrafine particles in humans. J Aerosol Sci. 2006;37:1152-1163.
19. Montoya LD, Lawrence J, Murthy GGK, Sarnat JA, Godleski JJ, and Koutrakis P: Continuous measurements of ambient particle deposition in human subjects. Aerosol Sci Technol. 2004;38:980-990.
20. Morawska L, Hofmann W, Hitchins-Loveday J, Swanson C, and Mengersen K: Experimental study of the deposition of combustion aerosols in the human respiratory tract. J Aerosol Sci. 2005;36:939-957.
21. Rosati JA, Brown JS, Peters TM, Leith D, and Kim CS: A polydisperse aerosol inhalation system designed for human studies. J Aerosol Sci. 2002;33:1433-1446.
22. Möller W, Felten K, Seitz J, Sornmerer K, Takenaka S, Wiebert P, Philipson K, Svartengren M, and Kreyling WG: A generator for the production of radiolabelled ultrafine carbonaceous particles for deposition and clearance studies in the respiratory tract. J Aerosol Sci. 2006;37:631-644.
23. Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Moller W, Sommerer K, Larsson S, and Svartengren M: Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J. 2006;28:286-290.
24. Jaques PA, and Kim CS: Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol. 2000;12:715-731.
25. Kim CS, and Jaques PA: Respiratory dose of inhaled ultrafine particles in healthy adults. Philos Trans R Soc Lond A Math Phys Eng Sci. 2000;358:2693-2705.
26. Kim CS, and Jaques PA: Analysis of total respiratory deposition of inhaled ultrafine particles in adult subjects at various breathing patterns. Aerosol Sci Technol. 2004;38: 525-540.
27. Fissan H, Neumann S, Trampe A, Pui DYH, and Shin WG: Rationale and principle of an instrument measuring lung deposited nanoparticle surface area. J Nanopart Res. 2007; 9:53-59.
28. Rosati JA, Leith D, and Kim CS: Monodisperse and polydisperse aerosol deposition in a packed bed. Aerosol Sci Technol. 2003;37:528-535.
29. Scheckman JH, and Mcmurry PH: Deposition of silica agglomerates in cast of human lung airways: enhancement relative to spheres of equal mobility and aerodynamic diameter. J Aerosol Sci. 2011;42:508-516.
30. Brain JD, and Valberg PA: Deposition of aerosol in the respiratory- tract. Am Rev Respir Dis. 1979;120:1325-1373.
31. Hinds W: Aerosol Technology, 2nd ed. John Wiley & Sons, Inc., New York; 1999.
32. Gebhart J: To the relevant diameter of aerosol particles in the 0.1 to 1 lM transition range. J Aerosol Sci. 1992;23 (Suppl 1):305-308.
33. Heyder J, Gebhart J, and Scheuch G: Interaction of diffusional and gravitational particle-transport in aerosols. Aerosol Sci Technol. 1985;4:315-326.
34. Schmid O, Karg E, Hagen DE, Whitefield PD, and Ferron GA: On the effective density of non-spherical particles as derived from combined measurements of aerodynamic and mobility equivalent size. J Aerosol Sci. 2007;38: 431-443.
35. Rissler J, Swietlicki E, Bengtsson A, Boman C, Pagels J, Sandström T, Blomberg A, and Löndahl J: Experimental determination of deposition of diesel exhaust particles in the human respiratory tract. J Aerosol Sci. 2012;48:18-33.
36. Schiller CF, Gebhart J, Heyder J, Rudolf G, and Stahlhofen W: Deposition of monodisperse insoluble aerosol particles in the 0.005 to 0.2 lm size range within the human respiratory tract. Ann Occup Hyg. 1988;32 (Suppl 1):41-49.
37. Löndahl J, Massling A, Pagels J, Swietlicki E, Vaclavik E, and Loft S: Size-resolved respiratory-tract deposition of fine and ultrafine hydrophobic and hygroscopic aerosol particles during rest and exercise. Inhal Toxicol. 2007;19: 109-116.
38. Tu KW, and Knutson EO: Total deposition of ultrafine hydrophobic and hygroscopic aerosols in the human respiratory system. Aerosol Sci Technol. 1984;3:453-465.
39. Anderson PJ, Wilson JD, and Hiller FC: Respiratory-tract deposition of ultrafine particles in subjects with obstructive or restrictive lung-disease. Chest. 1990;97:1115-1120.
40. Anselm A, Heibel T, Gebhart J, and Ferron G: "In vivo"- studies of growth factors of sodium chloride particles in the human respiratory tract. J Aerosol Sci. 1990;21:S427-S430.
41. Ferron GA: The size of soluble aerosol particles as a function of the humidity of the air. Application to the human respiratory tract. J Aerosol Sci. 1977;8:251-267.
42. Ferron GA, Kreyling WG, and Haider B: Inhalation of salt aerosol-particles. 2. Growth and deposition in the human respiratory-tract. J Aerosol Sci. 1988;19:611-631.
43. Löndahl J, Pagels J, Boman C, Swietlicki E, Massling A, Rissler J, Blomberg A, Bohgard M, and Sandstrom T: Deposition of biomass combustion aerosol particles in the human respiratory tract. Inhal Toxicol. 2008;20:923-933.
44. Pagels J, Khalizov AF, Mcmurry PH, and Zhang RY: Processing of soot by controlled sulphuric acid and water condensation - mass and mobility relationship. Aerosol Sci Technol. 2009;43:629-640.
45. Weingartner E, Burtscher H, and Baltensperger U: Hygroscopic properties of carbon and diesel soot particles. Atmos Environ. 1997;31:2311-2327.
46. Brown JS, Zeman KL, and Bennett WD: Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 2002;166:1240-1247.
47. Löndahl J, Swietlicki E, Rissler J, Bengtsson A, Boman C, Blomberg A, and Sandström T: Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease. Part Fibre Toxicol. 2012;9:30.
48. Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Haussinger K, and Kreyling WG: Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med. 2008;177:426-432.
49. Olvera HA, Perez D, Clague JW, Cheng YS, Li WW, Amaya MA, Burchiel SW, Berwick M, and Pingitore NE: The effect of ventilation, age, and asthmatic condition on ultrafine particle deposition in children. Pulm Med. 2012;2012:736290.
50. Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Moller W, Kreyling WG, and Svartengren M: No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol. 2006;18: 741-747.
51. Cheng YS, Yamada Y, Yeh HC, and Swift DL: Deposition of ultrafine aerosols in a human oral cast. Aerosol Sci Technol. 1990;12:1075-1081.
52. Yu CP: Theories of electrostatic lung deposition of inhaled aerosols. Ann Occup Hyg. 1985;29:219-227.
53. Cohen BS, Xiong JQ, Fang CP, and Li W: Deposition of charged particles on lung airways. Health Phys. 1998; 74:554-560.
54. Melandri C, Tarroni G, Prodi V, Dezaiacomo T, Formignani M, and Lombardi CC: Deposition of chargedparticles in the human airways. J Aerosol Sci. 1983;14:657-669.
55. Scheibel HG, and Porstendörfer J: Generation of monodisperse Ag- and NaCl-aerosol with particle diameters between 2 and 300 nm. J Aerosol Sci. 1983;14:113-126.
56. Lee CK, Ashtekar S, Gladden LF, and Barrie PJ: Adsorption and desorption kinetics of hydrocarbons in FCC catalysts studied using a tapered element oscillating microbalance (TEOM). Part 1: Experimental measurements. Chem Eng Sci. 2004;59:1131-1138.
57. Altshuler B, Yarmus L, Palmes ED, and Nelson N: Aerosol deposition in the human respiratory tract. Arch Ind Health. 1957;15:293-303.
58. Gebhart J, Schiller CF, Egan MJ, and Nixon W: On the relationship between experimental-data for total deposition and model-calculations. 1. Effect of instrumental dead space. J Aerosol Sci. 1989;20:141-147.
59. Thomas JW: Correction for dead space in face masks in inhalation studies. Am Ind Hyg Assoc J. 1967;28:39-42.
60. Brown JH, Cook KM, Ney FG, and Hatch T: Influence of particle size upon the retention of particulate matter in the human lung. Am J Public Health. 1950;40:450-480.
61. Landahl HD, Tracewell TN, and Lassen WH: On the retention of air-borne particulates in the human lung: II. AMA Arch Ind Hyg Occup Med. 1951;3:359-366.
62. Bennett WD, and Zeman KL: Effect of body size on breathing pattern and fine-particle deposition in children. J Appl Physiol. 2004;97:821-826.
63. Wang J, McNeill VF, Collins DR, and Flagan RC: Fast mixing condensation nucleus counter: application to rapid scanning differential mobility analyzer measurements. Aerosol Sci Technol. 2002;36:678-689.
64. Brown JS, Gerrity TR, Bennett WD, Kim CS, and House DE: Dispersion of aerosol boluses in the human lung - dependence on lung-volume, bolus volume, and gender. J Appl Physiol. 1995;79:1787-1795.
65. Brown JS, Kim CS, Reist PC, Zeman KL, and Bennett WD: Generation of radiolabeled "soot-like" ultrafine aerosols suitable for use in human inhalation studies. Aerosol Sci Technol. 2000;32:325-337.
66. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, and Frangioni JV: Renal clearance of quantum dots. Nat Biotechnol. 2007;25:1165-1170.
67. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, and Oberdorster G: Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol. 2009;21 (Suppl 1):55-60.
68. Jackson AM, Myerson JW, and Stellacci F: Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles. Nat Mater. 2004;3:330-336.
69. Blanchard JD, and Willeke K: Total deposition of ultrafine sodium-chloride particles in human lungs. J Appl Physiol. 1984;57:1850-1856.
70. Heyder J, Armbruster L, Gebhart J, Grein E, and Stahlhofen W: Total deposition of aerosol particles in the human respiratory tract for nose and mouth breathing. J Aerosol Sci. 1975;6:311-328.
71. Heyder J, Gebhart J, Heigwer G, Roth C, and Stahlhofen W: Experimental studies of the total deposition of aerosol particles in the human respiratory tract. J Aerosol Sci. 1973; 4:191-208.
72. Löndahl J, Massling A, Swietlicki E, Brauner EV, Ketzel M, Pagels J, and Loft S: Experimentally determined human respiratory tract deposition of airborne particles at a busy street. Environ Sci Technol. 2009;43:4659-4664.
73. Dombu CY, and Betbeder D: Airway delivery of peptides and proteins using nanoparticles. Biomaterials. 2013;34: 516-525.
74. Buxton D: The promise of nanotechnology for heart, lung and blood diseases. Expert Opin Drug Deliv. 2006;3: 173-175.
75. Lehnigk B, Schleiss M, Brand P, Heyder J, Magnussen H, and Jorres RA: Aerosol-derived airway morphometry (ADAM) in patients with lung emphysema diagnosed by computed tomography - reproducibility, diagnostic information and modelling. Eur J Med Res. 2007;12:74-83.
76. Swietlicki E, Hansson HC, Hameri K, Svenningsson B, Massling A, McFiggans G, Mcmurry PH, Petaja T, Tunved P, Gysel M, Topping D, Weingartner E, Baltensperger U, Rissler J, Wiedensohler A, and Kulmala M: Hygroscopic properties of submicrometer atmospheric aerosol particles measured with H-TDMA instruments in various environments - a review. Tellus B Chem Phys Meteorol. 2008;60:432-469.
77. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, and Donaldson K: Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-428.
78. Möller W, Meyer G, Scheuch G, Kreyling WG, and Bennett WD: Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J Aerosol Med Pulm Drug Deliv. 2009;22:333-339.
79. Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, and Sommerer K: Targeting delivery of aerosols to different lung regions. J Aerosol Med. 2002;15:179-188.
80. Chen DR, Pui DYH, and Kaufman SL: Electrospraying of conducting liquids for monodisperse aerosol generation in the 4 nm to 1.8 lm diameter range. J Aerosol Sci. 1995;26: 963-977.
81. Schiller CF, Gebhart J, Heyder J, Rudolf G, and Stahlhofen W: Factors influencing total deposition of ultrafine aerosolparticles in the human respiratory-tract. J Aerosol Sci. 1986;17:328-332.
82. Ku BK, and Maynard AD: Generation and investigation of airborne silver nanoparticles with specific size and morphology by homogeneous nucleation, coagulation and sintering. J Aerosol Sci. 2006;37:452-470.
83. Roth C: Generation of ultrafine gold aerosols. J Aerosol Sci. 1986;17:477-480.
84. Roth C, and Stahlhofen W: Radioactively labeled ultrafine particles for clearance measurements. J Aerosol Sci. 1990;21: S443-S446.
85. Burch WM, Sullivan PJ, and McLaren CJ: Technegas - a new ventilation agent for lung-scanning. Nucl Med Commun. 1986;7:865-871.
86. Roth C, Ferron GA, Karg E, Lentner B, Schumann G, Takenaka S, and Heyder J: Generation of ultrafine particles by spark discharging. Aerosol Sci Technol. 2004;38:228-235.
87. Schwyn S, Garwin E, and Schmidtott A: Aerosol generation by spark discharge. J Aerosol Sci. 1988;19:639-642.
88. Kreyling WG, Biswas P, Messing ME, Gibson N, Geiser M, Wenk A, Sahu M, Deppert K, Cydzik I, Wigge C, Schmid O, and Semmler-Behnke M: Generation and characterization of stable, highly concentrated titanium dioxide nanoparticle aerosols for rodent inhalation studies. J Nanopart Res. 2011;13:511-524.
89. Szymczak W, Menzel N, Kreyling WG, and Wittmaack K: TOF-SIMS characterisation of spark-generated nanoparticles made from pairs of Ir-Ir and Ir-C electrodes. Int J Mass Spectrom. 2006;254:70-84.
90. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, and Jakob T: Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol. 2006;117:824-830.
91. Chan TL, and Lippmann M: Experimental measurements and empirical modeling of the regional deposition of inhaled particles in humans. Am Ind Hyg Assoc J. 1980; 41:399-408.
92. George A, and Breslin AJ: Deposition of radon daughters in humans exposed to uranium mine atmospheres. Health Phys. 1969;17:115-124.
93. Holleman DF, Martz DE, and Schiager KJ: Total respiratory deposition of radon daughters from inhalation of uranium mine atmospheres. Health Phys. 1969;17: 187-192.
94. Hursh JB, and Mercer TT: Measurement of Pb-212 loss rate from human lungs. J Appl Physiol. 1970;28:268-274.
95. Wilson IB, and Lamer VK: The retention of aerosol particles in the human respiratory tract as a function of particle radius. J Ind Hyg Toxicol. 1948;30:265-280.
96. Haslbeck K, Schwarz K, Hohlfeld JM, Seume JR, and Koch W: Submicron droplet formation in the human lung. J Aerosol Sci. 2010;41:429-438.
97. Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ, and Frampton MW: Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol. 2003;15:539-552.
98. Baron A, and Willeke K: Aerosol Measurement: Principles, Techniques and Applications, Vol. 2. John Wiley & Sons, Inc., New York; 2005.
99. Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Riesenfeld E, Gelain R, Utell MJ, and Frampton MW: A facility for controlled human exposures to ultrafine particles. In: U Heinrich and U Mohr, (eds). Crucial Issues in Inhalation Research - Mechanistic, Clinical and Epidemiologic. ILSI Press, Washington, DC; pp. 241-253, 2002.
100. Wilson FJ, Hiller FC, Wilson JD, and Bone RC: Quantitative deposition of ultrafine stable particles in the human respiratory- tract. J Appl Physiol. 1985;58:223-229.
101. Lausted CG, Johnson AT, Scott WH, Johnson MM, Coyne KM, and Coursey DC: Maximum static inspiratory and expiratory pressures with different lung volumes. Biomed Eng Online. 2006;5:29.
102. Anderson PJ, Hiller FC, and Mazumder MK: Deposition of 0.02-0.2 lm particles in the human respiratory tract: effects of variations in respiratory pattern. Ann Occup Hyg. 1988;32(Suppl 1):91-99.
103. Hiller FC, Anderson PJ, and Mazumder MK: Deposition of sidestream cigarette-smoke in the human respiratory-tract. 2. Deposition of ultrafine smoke particles. Toxicol Lett. 1987;35:95-99.
104. Blanchard JD, and Willeke K: An inhalation system for characterizing total lung deposition of ultrafine particles. Am Ind Hyg Assoc J. 1983;44:846-856.
105. Gilbert R, Auchincloss JH Jr, Brodsky J, and Boden W: Changes in tidal volume, frequency, and ventilation induced by their measurement. J Appl Physiol. 1972;33: 252-254.
106. Keskinen J, Pietarinen K, and Lehtimaki M: Electrical lowpressure impactor. J Aerosol Sci. 1992;23:353-360.
107. DeCarlo PF, Kimmel JR, Trimborn A, Northway MJ, Jayne JT, Aiken AC, Gonin M, Fuhrer K, Horvath T, Docherty KS, Worsnop DR, and Jimenez JL: Field-deployable, highresolution, time-of-flight aerosol mass spectrometer. Anal Chem. 2006;78:8281-8289.
108. Fleming JS, Conway JH, Holgate ST, Moore EA, Hashish AH, Bailey AG, and Martonen TB: Evaluation of the accuracy and precision of lung aerosol deposition measurements from planar radionuclide imaging using simulation. Phys Med Biol. 1998;43:2423-2429.
109. Lee ZH, BerridgeMS, NelsonAD, andHealdDL: The effect of scatter and attenuation on aerosol deposition as determined by gamma scintigraphy. J Aerosol Med. 2001;14:167-183.
110. Pitcairn GR, and Newman SP: Tissue attenuation corrections in gamma scintigraphy. J Aerosol Med. 1997;10:187-198.
111. Wagner HN, Buchanan JW, and Szabo Z. Principles of Nuclear Medicine, 2nd ed. Elsevier Health Sciences, Philadelphia, PA; 1995.
112. Fleming JS: A technique for using CT images in attenuation correction and quantification in SPECT. Nucl Med Commun. 1989;10:83-97.
113. Lee ZH, Ljungberg M, Muzic RF, and Berridge MS: Usefulness and pitfalls of planar gamma-scintigraphy for measuring aerosol deposition in the lungs: a Monte Carlo investigation. J Nucl Med. 2001;42:1077-1083.
114. Fleming JS: Technique for the absolute measurement of activity using a gamma-camera and computer. Phys Med Biol. 1979;24:176-180.
115. Parker RP, Smith PH, and Taylor DM: Basic Science of Nuclear Medicine, 2nd ed. Churchill Livingstone, London; 2012.
116. Möller W, Felten K, Meyer G, Meyer P, Seitz J, and Kreyling WG: Corrections in dose assessment of Tc-99m radiolabeled aerosol particles targeted to central human airways using planar gamma camera imaging. J Aerosol Med Pulm Drug Deliv. 2009;22:45-54.
117. Eberl S, Chan HK, and Daviskas E: SPECT imaging for radioaerosol deposition and clearance studies. J Aerosol Med. 2006;19:8-20.
118. Forge NI, Mountford PJ, and Odoherty MJ: Quantification of Tc-99m lung radioactivity from planar images. Eur J Nucl Med. 1993;20:10-15.
119. Fleming JS, Conway JH, Bolt L, and Holgate ST: A comparison of planar scintigraphy and SPECT measurement of total lung deposition of inhaled aerosol. J Aerosol Med. 2003;16:9-19.
120. Macey DJ, and Marshall R: Absolute quantitation of radiotracer uptake in the lungs using a gamma-camera. J Nucl Med. 1982;23:731-734.
121. Ilowite JS, Smaldone GC, Perry RJ, Bennett WD, and Foster WM: Relationship between tracheo-bronchial particle clearance rates and sites of initial deposition in man. Arch Environ Health. 1989;44:267-273.
122. Goldoni M, Caglieri A, De Palma G, Longo S, Acampa O, Poli D, Manini P, Apostoli P, Franchini I, Corradi M, and Mutti A: Development and set-up of a portable device to monitor airway exhalation and deposition of particulate matter. Biomarkers. 2009;14:326-339.
123. Invernizzi G, Ruprecht A, De Marco C, Paredi P, and Boffi R: Residual tobacco smoke: measurement of its washout time in the lung and of its contribution to environmental tobacco smoke. Tob Control. 2007;16:29-33.
124. Invernizzi G, Boffi R, RuprechtAA, Barnes PJ, Kharitonov SA, and Paredi P: Real-time measurement of particulate matter deposition in the lung. Biomarkers. 2006;11:221-232.
125. Kim CS, and Jaques PA: Total lung deposition of ultrafine particles in elderly subjects during controlled breathing. Inhal Toxicol. 2005;17:387-399.
126. Morawska L, Barron W, and Hitchins J: Experimental deposition of environmental tobacco smoke submicrometer particulate matter in the human respiratory tract. Am Ind Hyg Assoc J. 1999;60:334-339.
127. Cheng YS, Yeh HC, Guilmette RA, Simpson SQ, Cheng KH, and Swift DL: Nasal deposition of ultrafine particles in human volunteers and its relationship to airway geometry. Aerosol Sci Technol. 1996;25:274-291.
128. Roth C, Scheuch G, and Stahlhofen W. Clearance measurements with radioactively labelled ultrafine particles. Inhal Part VII. 1994;38(Suppl 1):101-106.
129. Muir DCF, and Cena K: Deposition of ultrafine aerosols in the human respiratory-tract. Aerosol Sci Technol. 1987;6:183-190.
130. Prodi V, and Mularoni A: Electrostatic lung deposition experiments with humans and animals. Ann Occup Hyg. 1985;29:229-240.
131. Giacomelli-Maltoni G, Melandri C, Prodi V, and Tarroni G: Deposition efficiency of monodisperse particles in human respiratory tract. Am Ind Hyg Assoc J. 1972; 33:603-610.
132. Dautrebande L, Beckmann H, and Walkenhorst W: Studies on deposition of submicronic dust particles in the respiratory tract. Arch Ind Health. 1959;19:383-391.
133. Morrow PE, Mehrhof E, Casarett LJ, and Morken DA: An experimental study of aerosol deposition in human subjects. Arch Ind Health. 1958;18:292-298.
134. Landahl HD, Tracewell TN, and Lassen WH: Retention of air-borne particulates in the human lung. III. AMA Arch Ind Hyg Occup Med. 1952;6:508-511.